Navigation Links
Aspirin use appears linked with improved survival after colon cancer diagnosis
Date:3/31/2014

Bottom Line: Taking low doses of aspirin (which inhibits platelet function) after a colon cancer diagnosis appears to be associated with better survival if the tumor cells express HLA class I antigen.

Author: Marlies S. Reimers, M.D., Leiden University Medical Center, the Netherlands, and colleagues.

Background: Prior research has suggested aspirin use after a colorectal cancer diagnosis might improve survival. Although the precise mechanism of aspirin's anti-cancer effect is unknown, previous data suggest that aspirin may prevent distant metastasis in colorectal cancer.

How the Study Was Conducted: The study examined tissue from tumors from 999 patients with colon cancer who underwent surgery between 2002 and 2008. Tissue samples were examined for HLA class I antigen and prostaglandin endoperoxide synthase 2 (PTGS2). Most patients had colon cancer diagnosed at stage III or lower. Data on aspirin use (defined as patients given a prescription for aspirin for 14 days or more after colon cancer diagnosis) came from a prescription database.

Results: Of the 999 patients, 182 (18.2 percent) were aspirin users and among them there were 69 deaths (37.9 percent). There were 396 deaths among 817 nonusers of aspirin (48.5 percent). Aspirin use after colon cancer diagnosis was associated with improved overall survival compared with nonuse. The potential survival benefit of aspirin was strongest among patients with HLA I antigen expression. The molecular reasons underlying the effects of aspirin are not completely understood, but the authors suggest the results are likely the effect of aspirin on circulating tumor cells and their ability to develop into metastatic deposits.

Discussion: "We found that the survival benefit associated with low-dose aspirin use after a diagnosis of colon cancer was significantly associated with HLA class I antigen-positive tumors. In contrast, in patients whose tumors had lost their HLA class I antigen expression, aspirin use did not change the outcome."

(JAMA Intern Med. Published online March 31, 2014. doi:10.1001/jamainternmed.2014.511. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Authors made conflict of interest disclosures. This work was supported by an unrestricted grant from the Sloos-Alandt family. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Commentary: Aspirin as Adjuvant Therapy for Stage III Colon Cancer.

In a related commentary, Alfred I. Neugut, M.D., Ph.D., of Columbia University, New York, writes: "When one sees a patient newly diagnosed as having cancer, after finishing the initial discussion and treatment plan, it is almost inevitable that the patient or a family member will inquire, "What else should he [or she] do?"

"For my own patients, I have so far not recommended aspirin [for colon cancer]. But I think based on current evidence, that if I personally had a stage III tumor, I would add aspirin to my FOLFOX (folinic acid-flourouracil-oxaliplatin) adjuvant therapy. And if I feel that way for myself, should I not convey that to my patients?" Neugut continues.

"But for now, as far as I am concerned, when a patient or a patient's spouse asks, "What else should he be doing, Doctor?" I will have a ready response," Neugut concludes.


'/>"/>
Contact: Gerrit Jan Liefers
g.j.liefers@lumc.nl
The JAMA Network Journals
Source:Eurekalert

Related medicine news :

1. Report says new evidence could tip the balance in aspirin cancer prevention care
2. Aspirin as Effective as Warfarin for Heart Failure: Study
3. Some Diabetics May Not Benefit From Daily Aspirin
4. Aspirin protects against Barretts esophagus
5. Study adds to evidence daily aspirin linked to lower cancer mortality
6. Daily aspirin usage associated with lower cancer mortality
7. Daily Aspirin May Cut Cancer Deaths, Another Study Finds
8. Daily Aspirin May Help Fight Prostate Cancer, But Not Breast Cancer
9. Aspirin may help men with prostate cancer live longer, study suggests
10. Adding Plavix to Aspirin Doesnt Help Guard Against Second Stroke: Study
11. Gene mutation identifies colorectal cancer patients who live longer with aspirin therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... Cary, NC (PRWEB) , ... January 15, 2017 ... ... to announce that Albertsons Companies has achieved accreditation for its specialty care services. ... accreditation and its own in-house specialty care service for pharmacy patients. , Accreditation ...
(Date:1/15/2017)... ... 14, 2017 , ... Wondering where to go this Valentine's Day? Well, there ... for a romantic, lobster feast in the comfort of your own home. Lobster Gram ... dinners will be featured until February 15th, 2017. , Romantic Dinner one is ...
(Date:1/14/2017)... ... January 14, 2017 , ... Healthy living brand Moody ... activated charcoal products. With more and more people opting to go organic in ... how they cater to specific needs. , Moody Zook focused particularly on their ...
(Date:1/14/2017)... ... 14, 2017 , ... "TransFreeze Volume 3 is a self animating masking transition which allows users ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , TransFreeze Volume ... from one clip to the next. , To use “Cut-Out First” presets, choose ...
(Date:1/13/2017)... (PRWEB) , ... January 13, 2017 , ... A January ... top five procedures for 2017 according to the publication, with an emphasis on some ... Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., who is known more casually to his patients and ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... NEW YORK , Jan. 16, 2017 /PRNewswire/ ... global peripherally inserted central catheters market for the ... is to offer updates and information related to ... catheters market. This comprehensive market study demonstrates the ... current environment and future status of the global ...
(Date:1/16/2017)... , Jan. 16, 2017 The global pacemaker ... 2025, according to a new report by Grand View ... with the availability of medical coverage is a key ... addition, technological enhancements in these devices are supporting the ... Diseases (CVDs) is a high-impact growth rendering driver for ...
(Date:1/16/2017)... HOUSTON , Jan. 16, 2017 ... of Potts Law Firm, was recently appointed Liaison Counsel ... Proceedings (JCCP) for all Xarelto cases. In this role, ... plaintiff parties and will actively assist the Court and ... with Milstein Adelman Jackson Fairchild & ...
Breaking Medicine Technology: